Q2 2020 Fundings in San Diego

Q2 2020 Fundings in San Diego

June 30:

  • Poseida Therapeutics, $110M with Schonfeld Strategic Advisors, Fidelity, and Adage Capital Management
  • Artiva Biotherapeutics, $78M with 5AM Ventures, venBio Partners, RA Capital Management, and Medivate Partners, among others
  • ClickUp, $35M with Craft Ventures and Georgian Partners
  • Sun Genomics, $8.65M with Pangaea Ventures
  • Carlsmed, $2.5M with Wavemaker Three-Sixty Health and Device of Tomorrow Capital, among others
  • GroupSolver, $2M with Eterus Capital and Tech Coast Angels, among others

June 24:

  • Engrail Therapeutics, $32M with Nan Fung Life Sciences
  • Lassen Therapeutics, $31M with Longwood Funds, Frazier Healthcare Partners, and Alta Partners
  • Upcycle & Co, $825K with Tech Coast Angels, among others

June 16:

  • Cue, $100M with Madrone Capital Partners, Johnson & Johnson Innovation – JJDC, Foresite Capital, Decheng Capital, and ACME Capital
  • Autobahn Therapeutics, $76M with Section 32, Samsara BioCapital, Pfizer Venture Investments, Invus, Cowen Healthcare Investments, Bristol-Myers Squibb, Biotechnology Value Fund, Biogen Idec, Alexandria Venture Investments, and ARCH Venture Partners
  • Lycia Therapeutics, $50M with Versant Ventures
  • Glysens, $15M with Mcnair Interests and The Sarofim Group
  • Quidel, $635K with Biomedical Advanced Research and Development Authority

June 9:

  • Viacyte, $27M with Sanderling Ventures, Bain Capital Life Sciences, TPG Capital, and RA Capital Management
  • Gali Health, $3M with Tech Coast Angels San Diego, Felicis Ventures, BOLD Capital Partners, and Bob Nelson, among others
  • Simply Independent, $300k with Launch Factory

June 3:

  • Ascus Biosciences, $46M with Temasek Holdings, Formation 8, Cavallo Ventures, and Anterra Capital
  • Platform Science, $42M with Schematic Ventures, Prologis, NewRoad Capital Partners, Daimler Trucks North America, Cambridge Capital, and 8VC
  • CalciMedica, $15M with Valence Life Sciences, Sanderling Ventures, Mesa Verde Venture Partners, and Bearing Capital

May 26:

  • Amplyx, $90M with Sofinnova Investments, New Enterprise Associates, Lundbeckfonden Ventures, Arix Bioscience, Pappas Capital, RiverVest Venture Partners, 3×5 Partner s , BioMed Ventures, and Adage Capital Management
  • Ecwid, $42M with PeakSpan Capital and Morgan Stanley Expansion Capital
  • Chromacode, $10M with Adjuvant Capital

May 12:

  • Alume Biosciences, $5.5M with Dan Bradbury and Chrysa Mineo
  • Plantible Foods, $4.6M with Vectr, Lerer Hippeau, FTW Ventures, and Eighteen94 Capital
  • Redemption Games, amount undisclosed with AppLovin

April 28:

  • Erasca, $200M with ARCH Venture Partners, Cormorant Asset Management, EDBI, Terra Magnum Capital Partners, LifeSci Venture Partners, Colt Ventures, City Hill Ventures, and Invus
  • Brain Cor p, $36M with SoftBank Vision Fund 1, ClearBridge Investments, Satwik Ventures, and Qualcomm Ventures
  • Trovata, $4.3M with JP Morgan and FINTOP Capital
  • Intellecy, $125K with undisclosed investors

April 14:

  • Aspen Neuroscience, $70M with OrbiMed, Section 32, Sam Altman, Frazier Healthcare Partners, Domain Associates, and ARCH Venture Partners

 

  • AristaMD, $18M with Stanford Health Care, The CU Healthcare Innovation Fund, MemorialCare Innovation Fund, Cigna Ventures, and Avalon Ventures

 

  • Cue, $13M with Biomedical Advanced Research and Development Autho

March 31:

  • Design Therapeutics, $45M with SR One, Cormorant Asset Management, Quan Capital and West River Group

 

  • FLX Bike, $1.3M via crowdfunding equity

Leave a Reply